Skip to content

Gross margin at other companies

ITG
Integer HoldingsITGR
26.4%-0.6pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp
Haemonetics logo
HaemoneticsHAE
59%+4.0pp
Abbott logo
AbbottABT
56.3%+0.4pp
Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Calculated from LeMaitre Vascular’s reported figures.

Based on trailing twelve months.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's gross margin?
LeMaitre Vascular (LMAT) reported gross margin of 72.4% in Q1 2026.
How has LeMaitre Vascular's gross margin changed year-over-year?
LeMaitre Vascular's gross margin increased by 5.2% year-over-year, from 68.8% to 72.4%.
What is the long-term trend for LeMaitre Vascular's gross margin?
Over 5 years (2020 to 2025), LeMaitre Vascular's gross margin has grown at a 1.8% compound annual growth rate (CAGR), from 65.4% to 71.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.